Head neck cancer (HNC) is generally treated with a multimodality approach. Loco-regional-distant control is often worst, due to the advantage stage disease at diagnosis and the optimal treatment option remains an unresolved issue. Metronomic chemotherapy (MCHT) is an emerging therapeutic option in clinical oncology and it may prove useful in HNC patients.
|Titolo:||Metronomic chemotherapy in head and neck cancer|
DE FELICE, FRANCESCA (Corresponding author)
|Data di pubblicazione:||2017|
|Appartiene alla tipologia:||01g Articolo di rassegna (Review)|